Know Cancer

or
forgot password
  • cancer clinical trials in charlotte, NC

  • Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer
    Presbyterian Hospital Cancer Center
    Charlotte, North Carolina 28204
    Lung Cancer, Non Small Cell Lung Carcinoma
    Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer
    Blumenthal Cancer Center at Carolinas Medical Center

    Trial Locations
    Blumenthal Cancer Center at Carolinas Medical Center
    Presbyterian Cancer Center at Presbyterian Hospital
    Sarcoma
    Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
    Blumenthal Cancer Center at Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer
    Blumenthal Cancer Center at Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Sarcoma
    S0515 Combination Chemo, Rituximab, and Bevacizumab in Older Patients With Stage II-IV Diffuse Large B-Cell Lymphoma
    Blumenthal Cancer Center at Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Lymphoma
    Remission and Joint Damage Progression in Early Rheumatoid Arthritis
    Carolina Bone & Joint
    Charlotte, North Carolina 28210
    Rheumatoid Arthritis
    S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
    Presbyterian Cancer Center at Presbyterian Hospital
    Charlotte, North Carolina 28233-3549
    Multiple Myeloma
    Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients

    Charlotte, North Carolina
    Skin Neoplasms, Kidney Transplantation
    Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients
    Presbyterian Hospital Center for Cancer Research
    Charlotte, North Carolina 28204
    Prostate Cancer
    A Study of MDX-010 (BMS-734016) Administered With or Without Prophylactic Oral Budesonide
    Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Malignant Melanoma
    Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care

    Charlotte, North Carolina
    Acute Myeloid Leukemia
    Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin’s Lymphoma
    Presbyterian Hospital Cancer Center
    Charlotte, North Carolina 28204
    Lymphoma, Non-Hodgkin, Lymphoma, Low-Grade
    Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis
    Carolinas Medical Center - MS Center
    Charlotte, North Carolina 28207
    Multiple Sclerosis, Optic Neuritis, Transverse Myelitis, Acute Brainstem/Cerebellar Syndrome
    Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma
    Carolinas Hematology-Oncology Associates
    Charlotte, North Carolina 28203
    Multiple Myeloma
    Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease
    Site Ref # / Investigator 1855
    Charlotte, North Carolina 28207
    Crohn's Disease
    S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
    Presbyterian Cancer Center at Presbyterian Hospital
    Charlotte, North Carolina 28233-3549
    Sarcoma
    S0509: AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery
    Presbyterian Cancer Center at Presbyterian Hospital
    Charlotte, North Carolina 28233-3549
    Malignant Mesothelioma
    Trial of Decitabine in Patients With Acute Myeloid Leukemia

    Charlotte, North Carolina
    Acute Myeloid Leukemia
    A Long-term Safety Study of Infliximab (Remicade)

    Charlotte, North Carolina
    Arthritis, Rheumatoid, Crohn Disease, Psoriasis
    Study Testing the Biologic Activity and Safety of an Immunotherapeutic in Patients With Newly Diagnosed Stage IV Kidney Cancer
    Carolinas Medical Center/Blumenthal Cancer Center
    Charlotte, North Carolina 28203
    Renal Cell Carcinoma
    Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
    Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Stage I Lymphoepithelioma of the Nasopharynx, Stage I Squamous Cell Carcinoma of the Nasopharynx, Stage II Lymphoepithelioma of the Nasopharynx, Stage II Squamous Cell Carcinoma of the Nasopharynx, Stage III Lymphoepithelioma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx
    A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation

    Charlotte, North Carolina
    Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Mantle Cell Lymphoma
    Phase II Safety and Efficacy Study of Single-agent AT-101 in Patients With Relapsed or Refractory B-cell Malignancies

    Charlotte, North Carolina
    Follicular Lymphoma, Diffuse Large Cell Lymphoma, Mantle Cell Lymphoma, Small Lymphocytic Lymphoma, Chronic Lymphocytic Leukemia
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Efficacy and Safety of Aprotinin on Transfusion Requirements in Patients Undergoing Radical or Total Cystectomy

    Charlotte, North Carolina
    Blood Loss, Surgical, Postoperative Hemorrhage
    Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium
    Carolinas Hematology-Oncology Associates
    Charlotte, North Carolina 28203
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter
    Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
    Blumenthal Cancer Center at Carolinas Medical Center

    Trial Locations
    Blumenthal Cancer Center at Carolinas Medical Center
    Presbyterian Cancer Center at Presbyterian Hospital
    Neuroblastoma
    A Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic Regimen
    GSK Clinical Trials Call Center
    Charlotte, North Carolina 28203
    Lymphoma, Small Cleaved-Cell, Follicular, Lymphoma, Large-Cell, Follicular, Lymphoma, Follicular, Lymphoma, Non-Hodgkin
    Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase
    Neuroscience and Spine Center
    Charlotte, North Carolina 28207
    Multiple Sclerosis
    Ph 3 Randomized Study of Telcyta® + Liposomal Doxorubicin Vs Liposomal Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer
    Carolinas Medical Center

    Trial Locations
    Carolinas Medical Center
    Presbyterian Hospital
    Blumenthal Cancer Center
    Ovarian Neoplasms
    GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer
    Carolinas Hematology Oncology Associates
    Charlotte, North Carolina 28203
    Advanced Unresectable Pancreatic Cancer
    Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer
    Presbyterian Hospital
    Charlotte, North Carolina 28233-3549
    Colorectal Neoplasms
    A Trial of Two Daclizumab Dosing Strategies Vs. No Induction Treatment With Tacrolimus, MMF, & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients
    Carolina Medical Center
    Charlotte, North Carolina 28203
    Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients
    Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer
    Blumenthal Cancer Center at Carolinas Medical Center
    Charlotte, North Carolina 28232-2861
    Kidney Cancer, Leukemia, Lymphoma, Neurotoxicity, Peripheral Neuropathy, Sarcoma
    Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
    Blumenthal Cancer Center at Carolinas Medical Center

    Trial Locations
    Blumenthal Cancer Center at Carolinas Medical Center
    Presbyterian Cancer Center at Presbyterian Hospital
    Leukemia
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    Carolinas Medical Center

    Trial Locations
    Carolinas Medical Center
    Presbyterian Hospital
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
    Carolinas Hematology Oncology Associates
    Charlotte, North Carolina 28203
    Bladder Cancer, Transitional Cell Carcinoma, Metastasis
    A Study of R547 in Patients With Advanced Solid Tumors.

    Charlotte, North Carolina
    Neoplasms